Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep:44:102296.
doi: 10.1016/j.msard.2020.102296. Epub 2020 Jun 10.

Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees

Affiliations

Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees

Le H Hua et al. Mult Scler Relat Disord. 2020 Sep.

Abstract

Background: Neuroimmunology/multiple sclerosis is a rapidly evolving, but still poorly defined subspecialty. Fellowship training is not standardized, and there is substantial variability across sites. Outcomes of fellowship training have not yet been studied. We therefore examined early career choices of neuroimmunology/MS fellowship program graduates and solicited the perspective of current and recent trainees on their fellowship experience as well as opportunities to improve neuroimmunology education.

Methods: We developed a questionnaire to collect information about fellowship training experiences and current medical practice. We identified recent graduates based on records from US training programs and the National MS Society and electronically sent the survey to current trainees and recent graduates (within the last 5 years).

Results: We identified 179 current/recent trainees and successfully reached 157 with survey distributions. Ninety-five individuals (60.5%) returned surveys. Most graduates assumed an academic practice (68%) focused mostly or exclusively on MS and other CNS neuroimmune diseases (55%), and practiced in regions where there were ≥5 other neuroimmunology specialists (51%). Graduates felt well-prepared to manage diagnoses of MS and neuromyelitis optica spectrum disorders but their comfort with rarer CNS neuroimmune diseases varied substantially. Basic immunology, neuro-rheumatology, grant writing and neuro-rehabilitation were identified as high impact areas for cross-disciplinary didactic training. The majority of recent trainees (57%) favored standardizing a core neuroimmunology curriculum, and 48% favored developing a subspecialty certification.

Conclusions: This is the first study to examine practice outcomes and trainee experiences for neuroimmunology training programs. We anticipate that these data will help educators define a core curriculum for the subspecialty and identify complementary skill sets that enhance the traditional clinic-based model of teaching.

Keywords: Graduate medical education; Multiple sclerosis; Neuroimmunology.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Supplementary curricular options. Respondents were asked to identify areas where additional training would have enhanced their education. n = 88 completed surveys.
Fig. 2.
Fig. 2.
Self-reported exposure to neuro-immunologic diagnoses during fellowship training. n = 82–84 respondents. Med complications was defined as “neurologic complications of biologic drugs”. MS: multiple sclerosis, NMO: neuromyelitis optica, MOG: myelin-oligodendrocyte glycoprotein, AI: autoimmune, PNP: paraneoplastic, ID: infectious disease.

Similar articles

Cited by

References

    1. Comi G, Radaelli M, Soelberg Sorensen P, 2017. Evolving concepts in the treatment of relapsing multiple sclerosis. Lancet 389, 1347–1356. - PubMed
    1. Cree BAC, Bennett JL, Kim HJ, et al., 2019. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial. Lancet 394, 1352–1363. - PubMed
    1. Gallien P, Gich J, Sanchez-Dalmau BF, Feneberg W, 2014. Multidisciplinary management of multiple sclerosis symptoms. Eur. Neurol 72 (Suppl 1), 20–25. - PubMed
    1. Linnoila J, Pittock SJ, 2016. Autoantibody-associated central nervous system neurologic disorders. Semin. Neurol 36, 382–396. - PubMed
    1. Lopez-Chiriboga AS, Clardy SL, 2017. Emerging subspecialties in neurology: autoimmune neurology. Neurology 89, e129–e133. - PubMed